NURO(Delisted)
NeuroMetrixยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NURO
Neurometrix, Inc.
A company that develops proprietary medical devices used to diagnose and to treat chronic pain, nerve diseases, and sleep disorders
4B Gill Street, Woburn, Massachusetts 01801
--
NeuroMetrix, Inc., was founded in June 1996. NeuroMetrix is a commercial-stage neurotechnology company based in Woburn, Massachusetts. The company's mission is to improve the health of individuals and populations through Innovative Medical devices and technology solutions for pain syndromes and neurological diseases. The company's core expertise in biomedical engineering follows two decades of design, construction and marketing of medical devices that stimulate nerves and analyze nerve responses for diagnostic and therapeutic purposes. The company fully integrates internal capabilities covering R & D, manufacturing, regulatory affairs and compliance, sales and marketing, product fulfillment and customer support. The company owns extensive proprietary intellectual property.
Company Financials
EPS
NURO has released its 2023 Q4 earnings. EPS was reported at -1.43, versus the expected 0, missing expectations. The chart below visualizes how NURO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NURO has released its 2024 Q4 earnings report, with revenue of 582.82K, reflecting a YoY change of -55.77%, and net profit of -1.78M, showing a YoY change of -7.93%. The Sankey diagram below clearly presents NURO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
